hyaluronoglucosaminidase has been researched along with Embolism in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 14 (50.00) | 24.3611 |
| 2020's | 10 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| De-La-Garza-Castro, O; Elizondo-Omaña, RE; Guzman-Lopez, S; Hernandez-Garate, YAK; Quiroga-Garza, A; Salinas-Alvarez, Y; Soto-Dominguez, A; Welsh, EC | 1 |
| Chen, GJ; Chen, ML; Fu, Q; Lai, LY; Liang, LM; Zhang, DQ; Zhang, LX; Zheng, C; Zhou, GW | 1 |
| DeLorenzi, C | 3 |
| Chen, X; Chen, Y; Huang, X; Long, X; Wang, M; Wang, X; Zhao, Q | 1 |
| Feng, X; Shi, H; Wu, S; Wu, WTL; Zhang, L | 1 |
| Bai, XY; Chen, ML; Dai, Q; Lai, LY; Liang, LM; Tang, WQ; Yu, YT; Zhang, LX; Zhou, GW; Zhou, YC | 1 |
| Fragola, R; Nicoletti, GF; Rauso, R; Tartaro, G; Zerbinati, N | 1 |
| Diniz, S; Goldberg, RA; Hoenig, J; Ugradar, S | 1 |
| Hong, WJ; Liao, ZF; Luo, SK; Zhang, YL | 1 |
| Chesnut, C | 1 |
| Raimbault, C | 1 |
| Chen, Y; Luo, SK; Zhang, YL | 1 |
| Gold, MH; Lei, Y; Li, GF; Ouyang, HW; Tan, J; Zhu, Y | 1 |
| Hsu, Y; Li, J; Wang, P; Wang, Y; Xu, Y | 1 |
| Carruthers, A; Carruthers, JDA; Fagien, S; Rohrich, RJ; Weinkle, S | 1 |
| Chiang, C; Liu, K; Zhou, S | 3 |
| Deliligka, A; Demiri, E; Pavlidis, L; Spyropoulou, GA | 1 |
| Camuzard, O; Foissac, R; Kestemont, P | 1 |
| Chen, C; Chiang, C; Ho, DS; Liu, K; Zhang, H; Zhou, S | 1 |
| Li, W; Tian, W; Wang, H; Wang, M; Zhang, Y | 1 |
| MIREJOVSKY, P; SLUNSKY, R | 1 |
| SCHAPOSNIK, F | 1 |
| Carruthers, JD; Cohen, JL; Hirsch, RJ | 1 |
| Algvere, P; Balazs, EA | 1 |
2 review(s) available for hyaluronoglucosaminidase and Embolism
| Article | Year |
|---|---|
[What's new in interventional dermatology?]
Topics: Blindness; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Dermal Fillers; Dermatology; Embolism; Facial Muscles; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Lasers, Dye; Melanosis; Necrosis; Neurotoxins; Port-Wine Stain; Skin Aging; Tranexamic Acid; Viscosupplements | 2018 |
Blindness caused by cosmetic filler injection: a review of cause and therapy.
Topics: Biocompatible Materials; Blindness; Cosmetic Techniques; Durapatite; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intradermal; Subcutaneous Fat; Tissue Transplantation | 2014 |
26 other study(ies) available for hyaluronoglucosaminidase and Embolism
| Article | Year |
|---|---|
Hyaluronic Acid Embolism Treated with Subcutaneous High and Low Hyaluronidase Doses: Efficacy and Surrounding Tissue Effect.
Topics: Animals; Dermal Fillers; Disease Models, Animal; Dose-Response Relationship, Drug; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intra-Arterial; Injections, Subcutaneous; Rabbits | 2021 |
Efficacy of Percutaneous Intraarterial Facial/Supratrochlear Arterial Hyaluronidase Injection for Treatment of Vascular Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.
Topics: Arteries; Cosmetic Techniques; Dermal Fillers; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intra-Arterial; Necrosis | 2022 |
Commentary on: Efficacy of Percutaneous Intraarterial Facial/Supratrochlear Arterial Hyaluronidase Injection for Treatment of Vascular Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.
Topics: Cosmetic Techniques; Dermal Fillers; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase | 2022 |
Use of liquid concentrated growth factor in the management of necrotic tissue after facial vascular complications induced by hyaluronic acid injection.
Topics: Dermal Fillers; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Subcutaneous; Intercellular Signaling Peptides and Proteins; Ischemia; Necrosis | 2022 |
Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
Topics: Animals; Blindness; Dermal Fillers; Embolism; Hyaluronic Acid; Hyaluronoglucosaminidase; Models, Theoretical; Rabbits | 2020 |
Evaluation of Intraarterial Thrombolysis in Treatment of Cosmetic Facial Filler-Related Ophthalmic Artery Occlusion.
Topics: Adult; Angiography, Digital Subtraction; Blindness; Cosmetic Techniques; Dermal Fillers; Drug Therapy, Combination; Embolism; Eye; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intra-Arterial; Injections, Subcutaneous; Male; Ophthalmic Artery; Retrospective Studies; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Visual Acuity | 2020 |
Commentary on: Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
Topics: Animals; Blindness; Dermal Fillers; Embolism; Hyaluronic Acid; Hyaluronoglucosaminidase; Models, Theoretical; Rabbits | 2020 |
Transvascular Hydrolysis of Hyaluronic Acid Filler With Hyaluronidase: An Ex Vivo Study.
Topics: Arteries; Dermal Fillers; Embolism; Face; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrolysis; In Vitro Techniques; Jugular Veins; Regional Blood Flow | 2021 |
Generation of Filler Emboli as a Mechanism for Filler-Related Blindness.
Topics: Blindness; Cosmetic Techniques; Dermal Fillers; Durapatite; Embolism; Face; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intradermal; Models, Anatomic; Ophthalmic Artery; Regional Blood Flow; Skin | 2021 |
Artery Embolization Caused by a Cosmetic Filler Injection in the Hand.
Topics: Adult; Cosmetic Techniques; Dermal Fillers; Drug Therapy, Combination; Embolism; Female; Hand; Heparin, Low-Molecular-Weight; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Magnetic Resonance Angiography; Rejuvenation; Treatment Outcome; Ulnar Artery | 2021 |
New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events.
Topics: Capillaries; Clinical Protocols; Dermal Fillers; Dermatologic Surgical Procedures; Embolism; Face; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Subcutaneous; Ischemia; Practice Guidelines as Topic; Skin; Time Factors | 2017 |
Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler.
Topics: Adult; Blindness; Cosmetic Techniques; Dermal Fillers; Embolism; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Orbit; Recovery of Function | 2018 |
Experimentally Induced Arterial Embolism by Hyaluronic Acid Injection: Clinicopathologic Observations and Treatment.
Topics: Administration, Intravenous; Animals; Arterial Occlusive Diseases; Cosmetic Techniques; Disease Models, Animal; Embolism; Fibrinolytic Agents; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Urokinase-Type Plasminogen Activator; Viscosupplements | 2019 |
Treatment of skin soft tissue embolism after hyaluronic acid injection for injection rhinoplasty in Asian patients.
Topics: Adult; Anti-Inflammatory Agents; Asian People; Cicatrix, Hypertrophic; Dermal Fillers; Embolism; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Subcutaneous; Lasers, Dye; Low-Level Light Therapy; Male; Massage; Necrosis; Rhinoplasty; Skin; Time Factors; Vasodilator Agents; Young Adult | 2019 |
The Role of Hyaluronidase for the Skin Necrosis Caused by Hyaluronic Acid Injection-Induced Embolism: A Rabbit Auricular Model Study.
Topics: Animals; Dermal Fillers; Disease Models, Animal; Ear Auricle; Embolism; Female; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Subcutaneous; Necrosis; Rabbits; Random Allocation; Role; Skin; Treatment Outcome; Wound Healing | 2019 |
Intravenous Hyaluronidase with Urokinase as Treatment for Arterial Hyaluronic Acid Embolism.
Topics: Animals; Chi-Square Distribution; Disease Models, Animal; Drug Therapy, Combination; Embolism; Epigastric Arteries; Graft Survival; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intravenous; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion; Surgical Flaps; Urokinase-Type Plasminogen Activator | 2016 |
Intravenous Hyaluronidase with Urokinase as Treatment for Arterial Hyaluronic Acid Embolism.
Topics: Cosmetic Techniques; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Urokinase-Type Plasminogen Activator | 2016 |
Reply: Intravenous Hyaluronidase with Urokinase as Treatment for Arterial Hyaluronic Acid Embolism.
Topics: Cosmetic Techniques; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Urokinase-Type Plasminogen Activator | 2016 |
Intravenous Hyaluronidase with Urokinase as Treatment for Arterial Hyaluronic Acid Embolism.
Topics: Cosmetic Techniques; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Urokinase-Type Plasminogen Activator | 2016 |
Reply: Intravenous Hyaluronidase with Urokinase as Treatment for Arterial Hyaluronic Acid Embolism.
Topics: Cosmetic Techniques; Embolism; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Urokinase-Type Plasminogen Activator | 2016 |
Intravenous Hyaluronidase with Urokinase as Treatment for Rabbit Retinal Artery Hyaluronic Acid Embolism.
Topics: Animals; Cosmetic Techniques; Dermal Fillers; Drug Therapy, Combination; Embolism; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intravenous; Male; Rabbits; Random Allocation; Retinal Artery Occlusion; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2016 |
Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.
Topics: Animals; Dermal Fillers; Embolism; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intra-Arterial; Injections, Subcutaneous; Ligation; Male; Rabbits; Regional Blood Flow; Testis | 2017 |
[AMNIOTIC FLUID EMBOLISM AS A CAUSE OF BLOOD COAGULATION DISORDER].
Topics: Afibrinogenemia; Amniotic Fluid; Blood Coagulation Disorders; Embolism; Embolism, Amniotic Fluid; Female; Humans; Hyaluronoglucosaminidase; Pregnancy; Thrombocytopenia; Thromboplastin | 1963 |
[SHOCK IN OBSTETRICS].
Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Anti-Bacterial Agents; Blood Transfusion; Embolism; Female; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Mannitol; Morphine; Norepinephrine; Obstetrics; Phentolamine; Postpartum Hemorrhage; Postpartum Period; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Puerperal Infection; Sepsis; Shock; Shock, Hemorrhagic; Shock, Septic | 1964 |
Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.
Topics: Adjuvants, Immunologic; Adult; Blood Vessels; Embolism; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections, Intradermal; Necrosis; Nose; Skin | 2007 |
Experimental retinal detachment in owl monkeys. Effect of intravitreal hyaluronidase injection and embolization of the choroidal and retinal circulation.
Topics: Animals; Capillaries; Cattle; Choroid; Disease Models, Animal; Embolism; Fundus Oculi; Haplorhini; Hyaluronic Acid; Hyaluronoglucosaminidase; Injections; Ischemia; Leeches; Microscopy, Electron; Plastics; Regional Blood Flow; Retina; Retinal Detachment; Retinal Vein; Retinal Vessels; Serum Albumin, Bovine; Viscosity; Vitreous Body | 1974 |